
Yanelly Pharmaceuticals Private Limited
About Yanelly Pharmaceuticals Private Limited
Data last updated:
Yanelly Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 28 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24304MP2016PTC041740. Its GSTIN is 23AAACY8400B1ZW (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Deepak Kumar Mishra and Mani Khatri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhopal, Madhya Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.73 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹19,656 (net margin 1.5%) and EBITDA of ₹26,837 (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 17% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Yanelly Pharmaceuticals Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.N.B – 1/401 Fortune Signature E – 8 Bawadiya Kala, N, Bhopal, Madhya Pradesh, India – 462039
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Yanelly Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Yanelly Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Yanelly Pharmaceuticals Private Limited, buy the company report.
Financials of Yanelly Pharmaceuticals Private Limited
FY 2025 filings availableYanelly Pharmaceuticals Private Limited reported revenue of ₹12.73 Lakh (up 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 10% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26,837 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19,656 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Yanelly Pharmaceuticals Private Limited, buy the company report.
Board of directors of Yanelly Pharmaceuticals Private Limited
Yanelly Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Kumar Mishra Also directs: RMB Construction and Development Private Limited | Director | 28 Oct 2016 | 10 Years 0 Months | Current |
| Mani Khatri | Director | 25 Mar 2023 | 3 Years 7 Months | Current |
Auditor
Yanelly Pharmaceuticals Private Limited is audited by Mayank Kesharwani & Company for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mayank Kesharwani & Company | FY 2017 | 021949C |
Shareholding
The shareholding of Yanelly Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Yanelly Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Yanelly Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Yanelly Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Yanelly Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACY8400B1ZW | Madhya Pradesh | Active | 26 Aug 2017 |
To see the full GST registrations and return filing status of Yanelly Pharmaceuticals Private Limited, buy the company report.
Recent activity
Yanelly Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Mani Khatri ceased to be Additional Director on 29 Sep 2023.
Frequently asked questions
Yanelly Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 28 October 2016 (10+ years old) and is registered under CIN U24304MP2016PTC041740.
Yanelly Pharmaceuticals has 2 current directors:
- Deepak Kumar Mishra - Director
- Mani Khatri - Director
The latest financial statements of Yanelly Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Yanelly Pharmaceuticals is 23AAACY8400B1ZW, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Yanelly Pharmaceuticals is U24304MP2016PTC041740. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yanelly Pharmaceuticals was incorporated on 28 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
Mani Khatri ceased to be Additional Director on 29 Sep 2023. Kapil Khatri ceased to be Director on 25 Mar 2023. Mani Khatri was appointed as Director on 25 Mar 2023. Yanelly Pharmaceuticals has 4 board changes on record in total.
The registered office of Yanelly Pharmaceuticals is at H.N.B – 1401 Fortune Signature E – 8 Bawadiya Kala, N, Bhopal, Madhya Pradesh, India – 462039.
Yanelly Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Yanelly Pharmaceuticals is compliant as of 17 August 2026. The company is actively filing with the Registrar of Companies.

